Views

CrossRef citations to date

Altmetric

HEMOGLOBINOPATHY

Compliance and satisfaction with deferasirox (Exjade^®) compared with deferoxamine in patients with transfusion-dependent beta-thalassemia

Sezaneh HaghpanahHematology Research CenterShiraz University of Medical Sciences, Shiraz, Iran

Tahereh ZareiHematology Research CenterShiraz University of Medical Sciences, Shiraz, Iran

Zohreh ZahediHematology Research CenterShiraz University of Medical Sciences, Shiraz, Iran

Mehran KarimiHematology Research CenterShiraz University of Medical Sciences, Shiraz, IranCorrespondence[email protected]

Figures & data

Table 1. Comparison of the demographic characteristics of the patients with beta-thalassemia with regard to the type of ICT

Display Table

Table 2. Comparison of satisfaction with DFO and deferasirox in the patients with beta-thalassemia

Display Table

Table 3. Comparison of convenience with DFO and deferasirox in the patients with beta-thalassemia

Display Table

Table 4. Comparison of compliance with DFO and deferasirox in the patients with beta-thalassemia

Display Table

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Compliance and satisfaction with deferasirox (Exjade^®) compared with deferoxamine in patients with transfusion-dependent beta-thalassemia

Table 1. Comparison of the demographic characteristics of the patients with beta-thalassemia with regard to the type of ICT

Table 2. Comparison of satisfaction with DFO and deferasirox in the patients with beta-thalassemia

Table 3. Comparison of convenience with DFO and deferasirox in the patients with beta-thalassemia

Table 4. Comparison of compliance with DFO and deferasirox in the patients with beta-thalassemia

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Compliance and satisfaction with deferasirox (Exjade®) compared with deferoxamine in patients with transfusion-dependent beta-thalassemia

Figures & data

Table 1. Comparison of the demographic characteristics of the patients with beta-thalassemia with regard to the type of ICT

Table 2. Comparison of satisfaction with DFO and deferasirox in the patients with beta-thalassemia

Table 3. Comparison of convenience with DFO and deferasirox in the patients with beta-thalassemia

Table 4. Comparison of compliance with DFO and deferasirox in the patients with beta-thalassemia

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Compliance and satisfaction with deferasirox (Exjade^®) compared with deferoxamine in patients with transfusion-dependent beta-thalassemia